ZA200502122B - Tetrahydropyrimidine-2-one derivatives and their uses - Google Patents
Tetrahydropyrimidine-2-one derivatives and their uses Download PDFInfo
- Publication number
- ZA200502122B ZA200502122B ZA200502122A ZA200502122A ZA200502122B ZA 200502122 B ZA200502122 B ZA 200502122B ZA 200502122 A ZA200502122 A ZA 200502122A ZA 200502122 A ZA200502122 A ZA 200502122A ZA 200502122 B ZA200502122 B ZA 200502122B
- Authority
- ZA
- South Africa
- Prior art keywords
- compound
- hydroxy
- tetrahydropyrimidine
- nitro
- formula
- Prior art date
Links
- NQPJDJVGBDHCAD-UHFFFAOYSA-N 1,3-diazinan-2-one Chemical class OC1=NCCCN1 NQPJDJVGBDHCAD-UHFFFAOYSA-N 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 56
- 125000000217 alkyl group Chemical group 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 31
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 28
- 125000003545 alkoxy group Chemical group 0.000 claims description 20
- 230000035597 cooling sensation Effects 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 15
- 125000001188 haloalkyl group Chemical group 0.000 claims description 15
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 14
- 239000002324 mouth wash Substances 0.000 claims description 9
- 239000000606 toothpaste Substances 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 6
- 235000009508 confectionery Nutrition 0.000 claims description 6
- 235000015243 ice cream Nutrition 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 229940051866 mouthwash Drugs 0.000 claims description 5
- 229940034610 toothpaste Drugs 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- -1 hydroxy, cyano, nitro, mercapto, carbonyl Chemical group 0.000 description 40
- 125000005843 halogen group Chemical group 0.000 description 22
- 125000001424 substituent group Chemical group 0.000 description 15
- 125000003118 aryl group Chemical group 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 12
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- 229940041616 menthol Drugs 0.000 description 12
- 239000001257 hydrogen Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- 125000003342 alkenyl group Chemical group 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- RCEFMOGVOYEGJN-UHFFFAOYSA-N 3-(2-hydroxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one Chemical compound OC1=CC=CC=C1N1C(=O)NC(C=2C=C(C=CC=2)[N+]([O-])=O)=CC1 RCEFMOGVOYEGJN-UHFFFAOYSA-N 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000035807 sensation Effects 0.000 description 7
- 235000019615 sensations Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 125000004104 aryloxy group Chemical group 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 125000000547 substituted alkyl group Chemical group 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 125000004414 alkyl thio group Chemical group 0.000 description 5
- 125000005110 aryl thio group Chemical group 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 239000000825 pharmaceutical preparation Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 239000002781 deodorant agent Substances 0.000 description 4
- 229940127557 pharmaceutical product Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000003457 sulfones Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- SMMOAKJRCFZDRW-UHFFFAOYSA-N 3-(2-hydroxyphenyl)-6-phenyl-1,4-dihydropyrimidin-2-one Chemical compound OC1=CC=CC=C1N1C(=O)NC(C=2C=CC=CC=2)=CC1 SMMOAKJRCFZDRW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- FVTKUZQPWYVXEW-UHFFFAOYSA-N 1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one;hydrochloride Chemical compound Cl.CN(C)C(C)C(=O)C1=CC=CC(Cl)=C1 FVTKUZQPWYVXEW-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010016326 Feeling cold Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 239000008376 breath freshener Substances 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000077 insect repellent Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000008257 shaving cream Substances 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 125000003396 thiol group Chemical class [H]S* 0.000 description 2
- 235000019505 tobacco product Nutrition 0.000 description 2
- CXWGKAYMVASWDQ-UHFFFAOYSA-N 1,2-dithiane Chemical compound C1CCSSC1 CXWGKAYMVASWDQ-UHFFFAOYSA-N 0.000 description 1
- DKYBVKMIZODYKL-UHFFFAOYSA-N 1,3-diazinane Chemical compound C1CNCNC1 DKYBVKMIZODYKL-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- IMLSAISZLJGWPP-UHFFFAOYSA-N 1,3-dithiolane Chemical compound C1CSCS1 IMLSAISZLJGWPP-UHFFFAOYSA-N 0.000 description 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- UUWJBXKHMMQDED-UHFFFAOYSA-N 1-(3-chlorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(Cl)=C1 UUWJBXKHMMQDED-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- HTSABYAWKQAHBT-UHFFFAOYSA-N 3-methylcyclohexanol Chemical compound CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 1
- ZMGMDXCADSRNCX-UHFFFAOYSA-N 5,6-dihydroxy-1,3-diazepan-2-one Chemical group OC1CNC(=O)NCC1O ZMGMDXCADSRNCX-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000989913 Gunnera petaloidea Species 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 125000005957 acrydinyl group Chemical group 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- LOZWAPSEEHRYPG-UHFFFAOYSA-N dithiane Natural products C1CSCCS1 LOZWAPSEEHRYPG-UHFFFAOYSA-N 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- YFHXZQPUBCBNIP-UHFFFAOYSA-N fura-2 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=3OC(=CC=3C=2)C=2OC(=CN=2)C(O)=O)N(CC(O)=O)CC(O)=O)=C1 YFHXZQPUBCBNIP-UHFFFAOYSA-N 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 125000004970 halomethyl group Chemical group 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- VGIVLIHKENZQHQ-UHFFFAOYSA-N n,n,n',n'-tetramethylmethanediamine Chemical compound CN(C)CN(C)C VGIVLIHKENZQHQ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004626 naphthothienyl group Chemical group C1(=CSC2=C1C1=CC=CC=C1C=C2)* 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- HUGJIXPBNXUTDX-UHFFFAOYSA-N nitrosulfonylcarbamic acid Chemical compound OC(=O)NS(=O)(=O)[N+]([O-])=O HUGJIXPBNXUTDX-UHFFFAOYSA-N 0.000 description 1
- IVMHDOBGNQOUHO-UHFFFAOYSA-N oxathiane Chemical compound C1CCSOC1 IVMHDOBGNQOUHO-UHFFFAOYSA-N 0.000 description 1
- OOFGXDQWDNJDIS-UHFFFAOYSA-N oxathiolane Chemical compound C1COSC1 OOFGXDQWDNJDIS-UHFFFAOYSA-N 0.000 description 1
- OZQGLZFAWYKKLQ-UHFFFAOYSA-N oxazinane Chemical compound C1CCONC1 OZQGLZFAWYKKLQ-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005327 perimidinyl group Chemical group N1C(=NC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000004932 phenoxathinyl group Chemical group 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000002437 shaving preparation Substances 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000004627 thianthrenyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3SC12)* 0.000 description 1
- AJZGFFKDLABHDD-UHFFFAOYSA-N thiazinane Chemical compound C1CCSNC1 AJZGFFKDLABHDD-UHFFFAOYSA-N 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 210000000427 trigeminal ganglion Anatomy 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/204—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/205—Heterocyclic compounds
- A23L27/2054—Heterocyclic compounds having nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Seasonings (AREA)
- Confectionery (AREA)
- Seeds, Soups, And Other Foods (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0221697.6A GB0221697D0 (en) | 2002-09-18 | 2002-09-18 | Novel compouds and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200502122B true ZA200502122B (en) | 2006-05-31 |
Family
ID=9944340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200502122A ZA200502122B (en) | 2002-09-18 | 2005-03-14 | Tetrahydropyrimidine-2-one derivatives and their uses |
Country Status (10)
Country | Link |
---|---|
US (2) | US7045624B2 (pt) |
EP (1) | EP1546114B1 (pt) |
JP (1) | JP4959939B2 (pt) |
CN (1) | CN100506800C (pt) |
AU (1) | AU2003266321A1 (pt) |
BR (1) | BR0314447A (pt) |
GB (1) | GB0221697D0 (pt) |
RU (1) | RU2334741C2 (pt) |
WO (1) | WO2004026840A1 (pt) |
ZA (1) | ZA200502122B (pt) |
Families Citing this family (209)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010018579A1 (en) | 1998-12-18 | 2001-08-30 | Walter Klemp | Disposable absorbent garment having stretchable side waist regions |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US20070191797A1 (en) * | 2006-02-10 | 2007-08-16 | Roe Donald C | Absorbent article with sensation member |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
WO2004037225A2 (en) | 2002-10-25 | 2004-05-06 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
GB0229811D0 (en) * | 2002-12-20 | 2003-01-29 | Unilever Plc | Compound delivery systems |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
WO2005002582A2 (en) * | 2003-07-02 | 2005-01-13 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
NZ545747A (en) | 2003-08-06 | 2010-06-25 | Senomyx Inc | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
JP2005310310A (ja) * | 2004-04-23 | 2005-11-04 | Sanyo Electric Co Ltd | トラッキングバランス調整装置 |
US20060045953A1 (en) * | 2004-08-06 | 2006-03-02 | Catherine Tachdjian | Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers |
KR20100017599A (ko) * | 2005-01-04 | 2010-02-16 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 국소 냉감제 패치 조성물 |
CA2597134C (en) | 2005-02-04 | 2015-05-26 | Senomyx, Inc. | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
US7806880B2 (en) * | 2005-03-18 | 2010-10-05 | The Procter & Gamble Company | Pull-on wearable article with informational image |
US20060264858A1 (en) * | 2005-05-20 | 2006-11-23 | Roe Donald C | Multi-functional training garment |
WO2006131203A1 (en) * | 2005-06-10 | 2006-12-14 | Unilever N.V. | Oral care composition comprising a 1 , 2 , 3 , 6-tetrahydropyrimidine-2-one cooling agent |
AR055329A1 (es) | 2005-06-15 | 2007-08-15 | Senomyx Inc | Amidas bis-aromaticas y sus usos como modificadores de sabor dulce, saborizantes, y realzadores de sabor |
EP2559424A1 (en) | 2005-10-05 | 2013-02-20 | Kraft Foods Global Brands LLC | Cooling composition comprising trimethyl isopropyl butanamide |
MX2008000486A (es) | 2005-10-24 | 2008-03-07 | Teikoku Pharma Usa Inc | Composiciones topicas para el alivio del dolor de n-2,3-trimetil-2-isopropilbutamida y metodos para usar las mismas. |
US20070142798A1 (en) * | 2005-12-16 | 2007-06-21 | The Procter & Gamble Company | Disposable absorbent article having serviceable indicia indicating improper fit |
US7432413B2 (en) | 2005-12-16 | 2008-10-07 | The Procter And Gamble Company | Disposable absorbent article having side panels with structurally, functionally and visually different regions |
WO2007126430A1 (en) | 2005-12-23 | 2007-11-08 | Cadbury Adams Usa Llc | Compositions providing a heating sensation for oral or dermal delivery |
JP5203965B2 (ja) | 2005-12-23 | 2013-06-05 | クラフト・フーズ・グローバル・ブランズ・エルエルシー | メントールと同様の感覚をもたらす組成物 |
US20070233027A1 (en) * | 2006-03-31 | 2007-10-04 | The Procter & Gamble Company | Absorbent article with sensation member |
US8491558B2 (en) * | 2006-03-31 | 2013-07-23 | The Procter & Gamble Company | Absorbent article with impregnated sensation material for toilet training |
US8057450B2 (en) * | 2006-03-31 | 2011-11-15 | The Procter & Gamble Company | Absorbent article with sensation member |
US8664467B2 (en) * | 2006-03-31 | 2014-03-04 | The Procter & Gamble Company | Absorbent articles with feedback signal upon urination |
KR101387563B1 (ko) | 2006-04-21 | 2014-04-25 | 세노믹스, 인코포레이티드 | 고효능의 조미용 향료를 포함하는 식품 조성물 및 이의 제조 방법 |
US20090312384A1 (en) * | 2006-07-14 | 2009-12-17 | Stefan Michael Furrer | Benzimidazole As Cooling Compounds |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
EP2088979A2 (en) | 2006-12-04 | 2009-08-19 | The Procter & Gamble Company | Absorbent articles comprising graphics |
CN101583287A (zh) * | 2006-12-20 | 2009-11-18 | 奇华顿荷兰服务有限责任公司 | N-取代-对薄荷烷-3-甲酰胺及其用途 |
EP1958627A3 (de) | 2007-01-04 | 2010-09-01 | Symrise GmbH & Co. KG | Verwendung bestimmter Menthyl-3-oxocarbonsäureester als physiologisch wirksame Kühlsubstanzen |
EP1986473B1 (en) * | 2007-04-03 | 2017-01-25 | Tsinghua University | Organic electroluminescent device |
EP2008530B1 (de) | 2007-06-19 | 2011-01-19 | Symrise AG | Aromakomposition zum Verringern oder Unterdrücken von unerwünschtem bitteren und adstringierenden Eindruck |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
ES2395682T3 (es) | 2007-08-20 | 2013-02-14 | Symrise Ag | Derivados de ácido oxálico y su uso como principios activos refrescantes fisiológicos |
US20090110656A1 (en) * | 2007-10-31 | 2009-04-30 | Lemke Sarah A | Skin cooling composition |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
US20090157153A1 (en) * | 2007-12-13 | 2009-06-18 | Sarah Anne Lemke | Skin cooling system |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
WO2009089641A1 (en) * | 2008-01-17 | 2009-07-23 | Givaudan Sa | Benzimidazole derivatives and their use as cooling agents |
ES2828974T3 (es) * | 2008-08-26 | 2021-05-28 | Basf Se | Detección y uso de moduladores de bajo peso molecular del receptor de mentol frío TRPM8 |
WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
EP2295031B1 (de) | 2009-08-05 | 2018-01-10 | Symrise AG | Verwendung von Pterocarpanen als Anti-Cellulite-Wirkstoffe |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
WO2011064631A1 (en) | 2009-10-02 | 2011-06-03 | Foamix Ltd. | Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
ES2551693T3 (es) | 2009-10-06 | 2015-11-23 | Symrise Ag | Composición de limpieza dental que contiene mentol con percepción de amargor reducida |
US9446267B2 (en) | 2009-10-06 | 2016-09-20 | Symrise Ag | Products comprising a flavoring agent composition |
DE102010002558A1 (de) * | 2009-11-20 | 2011-06-01 | Symrise Ag | Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe |
EP2555745B1 (en) | 2010-04-08 | 2016-12-21 | Symrise AG | Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol |
RU2567175C2 (ru) | 2010-05-11 | 2015-11-10 | Симрайз Аг | Применение рубузозида для ослабления или подавления некоторых неприятных вкусовых ощущений |
EP2389922A1 (en) | 2010-05-25 | 2011-11-30 | Symrise AG | Cyclohexyl carbamate compounds as anti-ageing actives |
EP2394703B1 (de) | 2010-06-14 | 2015-12-23 | Symrise AG | Kühlmischungen mit verstärkter Kühlwirkung von 5-Methyl-2-(propan-2-yl)cyclohexyl-N-ethyloxamat |
US9029415B2 (en) | 2010-06-14 | 2015-05-12 | Symrise Ag | Cooling mixtures with an enhanced cooling effect of 5-methyl-2-(propane-2-yl)cyclohexyl-N-ethyloxamate |
EP2457554A1 (de) | 2010-11-24 | 2012-05-30 | Symrise AG | Menthol enthaltende Mischung |
EP2356977B1 (de) | 2011-02-02 | 2017-12-27 | Symrise AG | Zubereitungen mit Holzextrakten von Gleditschien |
EP2497458A1 (en) | 2011-03-08 | 2012-09-12 | B.R.A.I.N. Biotechnology Research And Information Network AG | Small molecule modulators of the cold and menthol receptor TRPM8 |
CA2839703A1 (en) | 2011-06-24 | 2012-12-27 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
MX2013015274A (es) | 2011-06-24 | 2014-03-31 | Amgen Inc | Anatagonista trpm8 y su uso en tratamientos. |
EP2758041B1 (de) | 2011-09-20 | 2021-01-13 | Basf Se | Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung |
WO2013170433A1 (en) | 2012-05-15 | 2013-11-21 | The Procter & Gamble Company | Absorbent article having characteristic waist end |
EP3398656B1 (en) | 2012-06-15 | 2023-01-11 | Symrise AG | Compositions comprising hyaluronan biosynthesis promoting agents |
WO2014005614A1 (en) | 2012-07-02 | 2014-01-09 | Symrise Ag | A method of flavouring a smoking product |
US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
EP2695597B1 (en) | 2012-08-07 | 2019-07-24 | Symrise AG | Cosmetic compositions |
EP2745878B1 (en) | 2012-12-19 | 2023-01-25 | Symrise AG | Cosmetic compositions |
PT2948129T (pt) | 2013-01-25 | 2018-02-12 | Wintermute Biomedical Inc | Compostos terapêuticos |
EP2764860A1 (en) | 2013-02-06 | 2014-08-13 | Basf Sa | Cupuassu fatty acid amidoamines and their derivatives |
ES2701758T3 (es) | 2013-02-27 | 2019-02-25 | Symrise Ag | Extracto de jengibre para la protección de citoblastos |
ES2686046T3 (es) | 2013-03-08 | 2018-10-16 | Symrise Ag | Composiciones antimicrobianas |
EP2774604B1 (en) | 2013-03-08 | 2017-08-30 | Symrise AG | Cosmetic compositions |
EP2783578A1 (en) | 2013-03-26 | 2014-10-01 | Symrise AG | Catechin reaction products |
EP2789369B1 (en) | 2013-04-14 | 2018-06-06 | Symrise AG | A composition for lightening skin and hair |
EP2807925A1 (en) | 2013-05-26 | 2014-12-03 | Symrise AG | Antimicrobial compositions |
EP2810934A1 (en) | 2013-06-09 | 2014-12-10 | Symrise AG | New succinate derivatives |
EP2842607B1 (en) | 2013-09-02 | 2018-05-30 | Symrise AG | A skin and/or hair whitening mixture |
WO2015040010A1 (en) | 2013-09-22 | 2015-03-26 | Cutech Srl | Extracts fo halimione portulacoides and their application |
EP2853254B1 (en) | 2013-09-26 | 2017-11-08 | Symrise AG | A composition for lightening skin and/or hair |
EP2859883B1 (en) | 2013-10-13 | 2019-05-15 | Symrise AG | Active mixtures comprising acylated oligopeptides and troxerutin |
EP2862852B1 (en) | 2013-10-18 | 2018-07-04 | Symrise AG | Urea derivatives for the protection of stem cells |
WO2015062629A1 (en) | 2013-10-29 | 2015-05-07 | Cutech Srl | Use of mono ornithine ketoglutarate (mokg) |
ES2643590T3 (es) | 2014-03-18 | 2017-11-23 | Symrise Ag | Dióxido de titanio revestido para reducir el efecto de blanqueamiento en la piel |
EP2932858A1 (de) | 2014-04-16 | 2015-10-21 | Symrise AG | Homovanillinsäure-Ester, insbesondere zum Erzielen eines Wärme- und/oder Schärfeeindrucks |
EP2962678A1 (en) | 2014-06-30 | 2016-01-06 | Symrise AG | Flavour and fragrance compositions comprising acetophenone derivatives |
EP3443950A1 (en) | 2014-07-30 | 2019-02-20 | Symrise AG | A fragrance composition |
DE102014015151A1 (de) * | 2014-10-13 | 2016-04-14 | Schlenk Metallic Pigments Gmbh | PVD-Metalleffektpigmentpulver |
EP3023090B1 (en) | 2014-11-21 | 2019-08-07 | Symrise AG | Compositions |
EP3045161A1 (en) | 2015-01-18 | 2016-07-20 | Symrise AG | Active compositions comprising 1,2-hexanediol and 1,2-octanediol |
EP3081207B1 (en) | 2015-04-16 | 2022-09-21 | Symrise AG | Use of a liposome composition |
EP3288534B1 (en) | 2015-04-28 | 2020-09-23 | Symrise AG | Compositions comprising valerian extracts |
US10568852B2 (en) | 2015-05-22 | 2020-02-25 | Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) | Combination compositions and their use in methods for treating obesity and obesity-related disorders |
EP3097905B1 (en) | 2015-05-28 | 2020-11-04 | Symrise AG | Cosmetic compositions |
EP3367994B1 (en) | 2015-10-28 | 2021-05-12 | Symrise AG | Method for inhibiting or masking fishy odours |
KR102636229B1 (ko) | 2015-11-15 | 2024-02-13 | 시므라이즈 아게 | 피부상의 쓰라림 (stining sensation) 경감 |
WO2017097434A1 (en) | 2015-12-06 | 2017-06-15 | Symrise Ag | A fragrance composition |
ES2855176T3 (es) | 2015-12-10 | 2021-09-23 | Symrise Ag | Composición con sabor y olor estabilizados |
EP3090726B1 (en) | 2015-12-21 | 2019-05-29 | Thiocyn GmbH | Cosmetic composition comprising a combination of active substances |
EP3090727B8 (en) | 2016-01-13 | 2019-06-19 | Thiocyn GmbH | Hair growth composition |
JP2019510062A (ja) | 2016-03-30 | 2019-04-11 | シムライズ アーゲー | 活性成分混合物 |
CN109475490B (zh) | 2016-05-23 | 2021-11-30 | 西姆莱斯股份公司 | 含有麦麸提取物的毛发护理混合物 |
WO2018036625A1 (en) | 2016-08-20 | 2018-03-01 | Symrise Ag | A preservative mixture |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
MX2018014358A (es) | 2016-10-11 | 2019-03-14 | Symrise Ag | Composiciones antimicrobianas. |
CN110149795B (zh) | 2016-12-02 | 2023-10-03 | 西姆莱斯股份公司 | 化妆品混合物 |
CN106619141A (zh) * | 2016-12-20 | 2017-05-10 | 天津盛易联科技股份有限公司 | 一种口腔科学用牙齿修复新产品及其制备方法 |
EP3579855A4 (en) | 2017-02-13 | 2020-12-16 | Wintermute Biomedical, Inc. | ANTI-PATHOGENIC THERAPEUTIC COMPOSITIONS |
IT201700090929A1 (it) | 2017-08-07 | 2019-02-07 | Cutech S R L | Usi cosmetici e medici di estratti del fungo Coprinus comatus per la regolazione dell’unità pilo sebacea. |
DE202017007679U1 (de) | 2017-08-09 | 2024-03-15 | Symrise Ag | 1,2-Alkandiole |
EP4331684A3 (en) | 2017-08-09 | 2024-05-29 | Symrise AG | 1,2-alkanediols |
BR112020003545B1 (pt) | 2017-08-23 | 2022-08-23 | Symrise Ag | Uso de extrato de isochrysis sp, e método para influenciar ou modificar a fibra capilar |
WO2019037844A1 (en) | 2017-08-23 | 2019-02-28 | Symrise Ag | NOVEL NATURAL BUTTER COMPOSITIONS AND USES THEREOF |
JP7231617B2 (ja) | 2017-08-31 | 2023-03-01 | ビーエーエスエフ ソシエタス・ヨーロピア | 生理学的冷涼活性成分の使用、及びそのような活性成分を含む組成物 |
EP3687311A1 (de) | 2017-09-27 | 2020-08-05 | Symrise AG | Amide zur erzeugung eines trigeminalen effekts |
US20230134686A1 (en) | 2017-10-10 | 2023-05-04 | Symrise Ag | Compositions containing benzoic acid or furoic acid derivatives and use of the derivatives for emulsion and foam stability |
CA3078909A1 (en) | 2017-10-16 | 2019-04-25 | Takasago International Corporation | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative |
EP3700352B1 (en) | 2017-10-23 | 2021-09-22 | Symrise AG | Aroma composition |
WO2019170222A1 (en) | 2018-03-06 | 2019-09-12 | Symrise Ag | Encapsulated active substance deposition on hairs and textile |
AU2018411527A1 (en) | 2018-03-08 | 2020-09-17 | Symrise Ag | Mixtures comprising a protein extract for the treatment of human skin and/or hair |
BR112020021624B1 (pt) | 2018-04-24 | 2024-02-06 | Symrise Ag | Cápsulas núcleo-casca, produto, processo para produzir as referidas cápsulas e uso dos mesmos |
CN117771250A (zh) | 2018-06-29 | 2024-03-29 | 因赛特公司 | Axl/mer抑制剂的制剂 |
WO2020015816A1 (de) | 2018-07-16 | 2020-01-23 | Symrise Ag | Zusammensetzung zur substitution von zucker in backwaren |
MX2021002327A (es) | 2018-08-27 | 2021-04-28 | Symrise Ag | Mezcla antimicrobiana. |
AU2018441463A1 (en) | 2018-09-14 | 2021-03-25 | Symrise Ag | A hair care composition |
BR122024000623A2 (pt) | 2018-09-20 | 2024-02-27 | Symrise Ag | Composições compreendendo 1,2-pentanodiol inodoro |
US20220000825A1 (en) | 2018-10-01 | 2022-01-06 | Wintermute Biomedical, Inc. | Therapeutic compositions |
WO2020069762A1 (en) | 2018-10-05 | 2020-04-09 | Symrise Ag | A method for fighting female body odors |
WO2020088778A1 (en) | 2018-11-02 | 2020-05-07 | Symrise Ag | A liquid and transparent blend of uv filters |
MX2021005418A (es) | 2018-11-08 | 2021-07-06 | Symrise Ag | Una composicion a base de agente tensioactivo antimicrobiano. |
CN116806825A (zh) | 2019-01-17 | 2023-09-29 | 西姆莱斯股份公司 | 一种抗微生物混合物 |
US20220071933A1 (en) | 2019-01-18 | 2022-03-10 | Symrise Ag | Combination remedy |
US20220183937A1 (en) | 2019-03-11 | 2022-06-16 | Symrise Ag | Method for improving the performance of a fragrance or a fragrance mixture |
US11938208B2 (en) | 2019-03-12 | 2024-03-26 | Symrise Ag | Antimicrobial mixture |
WO2020192865A1 (en) | 2019-03-22 | 2020-10-01 | Symrise Ag | Plant peptides and their applications |
BR112021018763A2 (pt) | 2019-03-22 | 2021-11-23 | Symrise Ag | Peptídeos vegetais e suas aplicações (ii) |
KR20220024533A (ko) | 2019-06-13 | 2022-03-03 | 시므라이즈 아게 | 쿨링 제제 (Cooling Preparation) |
US20220354772A1 (en) | 2019-07-02 | 2022-11-10 | Symrise Ag | Blend of beeswax and a lactylate ester |
CN114364773A (zh) | 2019-09-04 | 2022-04-15 | 西姆莱斯股份公司 | 芳香油混合物 |
JP2023510996A (ja) | 2019-10-16 | 2023-03-16 | シムライズ アーゲー | 皮膚への活性剤の間接的な浸透を目的とした使い捨てでない多用途用品 |
WO2021228352A1 (en) | 2020-05-11 | 2021-11-18 | Symrise Ag | A fragrance composition |
JP2023525987A (ja) | 2020-05-11 | 2023-06-20 | シムライズ アーゲー | 固体粘着性組成物 |
EP4096714A1 (en) | 2020-05-22 | 2022-12-07 | Firmenich SA | Compositions for reducing salty taste and uses thereof |
JP2023527492A (ja) | 2020-06-03 | 2023-06-29 | フイルメニツヒ ソシエテ アノニム | 雑味を減らす組成物およびその使用 |
WO2021259945A1 (en) | 2020-06-24 | 2021-12-30 | Firmenich Sa | Sweetening compositions and uses thereof |
EP4110475A1 (en) | 2020-07-14 | 2023-01-04 | Firmenich SA | Reduction of undesirable taste notes in oral care products |
CN116322326A (zh) | 2020-08-06 | 2023-06-23 | 西姆莱斯股份公司 | 聚脲/聚氨酯微胶囊 |
EP3969164A1 (de) | 2020-08-06 | 2022-03-23 | Symrise AG | Verfahren zur herstellung von mikrokapseln |
JP2023541748A (ja) | 2020-09-22 | 2023-10-04 | フイルメニツヒ ソシエテ アノニム | サリチル酸メチル不含のウィンターグリーンフレーバー組成物 |
WO2022111793A1 (en) | 2020-11-24 | 2022-06-02 | Symrise Ag | Medicament for accelerated wound healing |
EP4175490A1 (en) | 2020-11-29 | 2023-05-10 | Firmenich SA | Compositions that reduce peroxide off taste and uses thereof |
WO2022111829A1 (en) | 2020-11-30 | 2022-06-02 | Symrise Ag | Essential oils of citrus fruits for use as medicament for induced, increased and/or accelerated autophagy in human keratinocytes |
WO2022122122A1 (en) | 2020-12-08 | 2022-06-16 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (i) |
WO2022122133A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising uv-filters and one or more (bio)-alkanediols |
WO2022122135A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising (bio)-alkanediols with antimicrobials for product protection |
WO2022122131A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising lipophilic compounds and one or more (bio)-alkanediols |
WO2022122138A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Multifunctional compound mixtures comprising multiple (bio)-alkanediols |
WO2022122132A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising natural polymers and one or more (bio)-alkanediols |
WO2022122136A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising one or more (bio)-alkanediols with antioxidants |
WO2022122140A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising one or more (bio)-alkanediols with active ingredients |
WO2022122134A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions with (bio)-alkanediols and cooling agents |
WO2022122137A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising antimicrobials and (bio)-alkanediols for skin protection |
WO2022122167A1 (en) | 2020-12-11 | 2022-06-16 | Symrise Ag | Medicament for preventing or treating pathologic conditions of human skin (i) |
WO2022128052A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin |
WO2022128051A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (ii) |
WO2022128054A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
WO2022128057A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for prevention and treatment of collagen degradation in human connecting tissue |
WO2022128050A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammation and pain |
WO2022128048A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for preventing or treating pathologic conditions of human skin |
JP2024503845A (ja) | 2021-01-13 | 2024-01-29 | フィルメニッヒ インコーポレイテッド | 清涼効果を増強する組成物 |
WO2022161593A1 (en) | 2021-01-26 | 2022-08-04 | Symrise Ag | Medicament for accelerated wound healing |
CN116963710A (zh) | 2021-02-12 | 2023-10-27 | 西姆莱斯股份公司 | 预防和治疗色素沉着过度的药物 |
WO2022214187A1 (en) | 2021-04-08 | 2022-10-13 | Symrise Ag | An o/w emulsion base and emulsions comprising the same |
US20240173227A1 (en) | 2021-04-13 | 2024-05-30 | Symrise Ag | A fragrance mixture containing isocitronellol |
EP4326251A1 (en) | 2021-04-19 | 2024-02-28 | Symrise AG | Compositions comprising cannabidiol and, optionally, bisabolol |
EP4083050A1 (en) | 2021-05-01 | 2022-11-02 | Analyticon Discovery GmbH | Microbial glycolipids |
WO2022251628A1 (en) | 2021-05-28 | 2022-12-01 | Firmenich Incorporated | Compositions that enhance the cooling effect |
CN117693332A (zh) | 2021-06-24 | 2024-03-12 | 弗门尼舍有限公司 | 口腔护理组合物 |
WO2023274956A1 (en) | 2021-06-30 | 2023-01-05 | Firmenich Sa | Fast drying perfume composition |
WO2023006234A1 (en) | 2021-07-30 | 2023-02-02 | Symrise Ag | Biobased core-shell microcapsules |
WO2023117643A1 (en) | 2021-12-23 | 2023-06-29 | Firmenich Sa | Antimicrobial composition having encapsulated colorant |
WO2023148253A1 (de) | 2022-02-02 | 2023-08-10 | Symrise Ag | Verfahren zur herstellung von mikrokapseln |
WO2023147855A2 (de) | 2022-02-02 | 2023-08-10 | Symrise Ag | Verfahren zur herstellung von mikrokapseln |
WO2024011086A1 (en) | 2022-07-07 | 2024-01-11 | Firmenich Incorporated | Compositions that enhance the cooling effect |
WO2022207944A2 (en) | 2022-07-11 | 2022-10-06 | Symrise Ag | Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide |
WO2024028515A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Composition comprising a uv-filter stabilizer |
WO2024027931A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Odor and colorant stabilized compositions |
WO2024028514A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Composition with improved spf and uva photoprotection |
WO2024027926A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Composition comprising a uv-filter stabilizer |
WO2024027930A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Compositions comprising an antimicrobial boosting agent |
WO2024028512A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Compositions comprising an antimicrobial boosting agent |
WO2024027928A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Composition with improved spf and uva photoprotection |
WO2024028513A1 (en) | 2022-08-05 | 2024-02-08 | Symrise Ag | Odor and colorant stabilized compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3821221A (en) * | 1970-08-25 | 1974-06-28 | Delmar Chem | 1,2,3,6-tetrahydropyrimidine-2-one compounds and processes for makingthem |
JPH0887120A (ja) * | 1994-09-19 | 1996-04-02 | Fuji Electric Co Ltd | 電子写真用感光体 |
CA2483090C (en) * | 2002-05-02 | 2011-01-25 | Cragmont Pharmaceuticals, Llc | Use of therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions |
-
2002
- 2002-09-18 GB GBGB0221697.6A patent/GB0221697D0/en not_active Ceased
-
2003
- 2003-08-26 RU RU2005111243/04A patent/RU2334741C2/ru not_active IP Right Cessation
- 2003-08-26 AU AU2003266321A patent/AU2003266321A1/en not_active Abandoned
- 2003-08-26 EP EP03797254.4A patent/EP1546114B1/en not_active Expired - Lifetime
- 2003-08-26 JP JP2004536964A patent/JP4959939B2/ja not_active Expired - Fee Related
- 2003-08-26 CN CNB038251248A patent/CN100506800C/zh not_active Expired - Fee Related
- 2003-08-26 BR BR0314447-0A patent/BR0314447A/pt not_active Application Discontinuation
- 2003-08-26 WO PCT/EP2003/009566 patent/WO2004026840A1/en active Application Filing
- 2003-09-17 US US10/664,367 patent/US7045624B2/en not_active Expired - Fee Related
-
2005
- 2005-03-14 ZA ZA200502122A patent/ZA200502122B/en unknown
-
2006
- 2006-01-10 US US11/328,534 patent/US20060106217A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP4959939B2 (ja) | 2012-06-27 |
JP2006512294A (ja) | 2006-04-13 |
CN100506800C (zh) | 2009-07-01 |
AU2003266321A1 (en) | 2004-04-08 |
US20060106217A1 (en) | 2006-05-18 |
EP1546114B1 (en) | 2015-09-30 |
CN1694872A (zh) | 2005-11-09 |
US20040067970A1 (en) | 2004-04-08 |
WO2004026840A1 (en) | 2004-04-01 |
EP1546114A1 (en) | 2005-06-29 |
RU2334741C2 (ru) | 2008-09-27 |
GB0221697D0 (en) | 2002-10-30 |
RU2005111243A (ru) | 2005-10-27 |
US7045624B2 (en) | 2006-05-16 |
BR0314447A (pt) | 2005-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7045624B2 (en) | Compounds and their uses | |
JP5956036B2 (ja) | 冷メントール受容体trpm8の低分子量モジュレーターの検出および使用 | |
AU2006311826B2 (en) | Hydrazone derivatives and uses thereof | |
JP3245748B2 (ja) | p−メンタン誘導体並びにこれを含有する冷感剤 | |
CN101184470A (zh) | 清凉化合物 | |
AU2020200697A1 (en) | Synthesis of cyclohexane ester derivatives useful as sensates in consumer products | |
EP1817000B1 (en) | Thienopyrimidines as cooling agents | |
US20060280697A1 (en) | Composition | |
AU2019229433A1 (en) | Synthesis of cyclohexane carboxamide derivatives useful as sensates in consumer products | |
JPH02290827A (ja) | 1―アルコキシ―3―l―メントキシプロパン―2―オール並びにこれを含有する冷感剤及び冷感性組成物 | |
CN114761385A (zh) | Trpm8调节剂 | |
JPH05255186A (ja) | 3−置換−p−メンタン誘導体並びにこれを含有する 冷感剤 | |
KR20040007508A (ko) | 3-알킬(4,5-디페닐이미다졸-1-일)계의 신규의 화합물 및진정제로서의 이의 용도 | |
JP2005041783A (ja) | 清涼剤 | |
KR20030090789A (ko) | 3-알킬(4,5-디페닐이미다졸-1-일)계의 화합물 및진정제로서의 그의 용도 | |
JPH0335313B2 (pt) |